Hospital
Ahmc Whittier Hospital Medical
Ahmc Whittier Hospital Medical was paid $15.12M by Medicaid between Jan 2018 and Dec 2024, across 223 billing codes. Its largest line is 0450, Emergency room services — 19% of everything it billed.
33Billing provider infoAHMC WHITTIER HOSPITAL MEDICAL
WHITTIER, CA 90605
WHITTIER, CA 90605
33aNPI1023000569assigned 08/19/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$15.12M
24GClaims699,340
24DCodes billed223
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#146 of 410
Median peer was paid$6.90M
This provider vs. median2.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official MARSH, LINDA controls 11+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 127,207 | $2.58M | |
| 2019 | 119,443 | $3.08M | |
| 2020 | 91,360 | $2.03M | |
| 2021 | 81,898 | $1.75M | |
| 2022 | 95,108 | $2.06M | |
| 2023 | 100,004 | $1.95M | |
| 2024incomplete | 84,320 | $1.66M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0450 | Emergency room services | 19% | 61,080 | 55,751 | $2.91M |
| 0270 | 5.6% | 47,229 | 26,867 | $852K | |
| 70450 | Computed tomography, head or brain; without contrast material | 4.5% | 7,013 | 6,821 | $686K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 4.3% | 6,377 | 6,186 | $648K |
| J3490 | Unclassified drugs | 3.2% | 43,815 | 17,188 | $476K |
| Z7502 | 3.1% | 12,883 | 12,699 | $472K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 2.5% | 17,783 | 16,380 | $377K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 2.3% | 8,158 | 7,213 | $342K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.8% | 6,592 | 6,291 | $275K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.7% | 14,044 | 13,115 | $262K |
| 99199 | Unlisted special service, procedure or report | 1.7% | 6,453 | 5,711 | $253K |
| 80053 | Comprehensive metabolic panel | 1.6% | 12,100 | 11,380 | $242K |
211 more codes
| J7030 | Infusion, normal saline solution , 1000 cc | 1.6% | 10,028 | $239K |
| S3620 | Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total) | 1.6% | 1,614 | $237K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.4% | 4,033 | $217K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 1.3% | 4,176 | $192K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.3% | 4,123 | $190K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.2% | 5,971 | $187K |
| 71045 | Radiologic examination, chest; single view | 1.2% | 14,890 | $179K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.2% | 8,376 | $175K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 1.2% | 3,458 | $175K |
| Z7610 | 1.1% | 11,698 | $174K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.1% | 26,766 | $167K |
| 0942 | 1.1% | 9,026 | $164K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 1.0% | 1,316 | $159K |
| Z6412 | 1.0% | 5,993 | $156K | |
| Z9725 | <1% | 3,430 | $148K | |
| 0250 | <1% | 19,309 | $128K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 705 | $125K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 2,795 | $122K |
| Z7500 | <1% | 3,191 | $109K | |
| 84484 | <1% | 10,190 | $102K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 5,024 | $99K |
| Z6410 | <1% | 4,158 | $99K | |
| 72131 | <1% | 820 | $97K | |
| 81001 | <1% | 23,868 | $95K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 2,957 | $93K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 1,901 | $90K |
| Z6500 | <1% | 458 | $89K | |
| 0760 | <1% | 4,570 | $88K | |
| 99283 | Emergency room visit (moderate) | <1% | 1,620 | $86K |
| 83880 | <1% | 4,473 | $86K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 3,949 | $84K |
| 80076 | <1% | 11,805 | $84K | |
| 0762 | <1% | 391 | $80K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 8,215 | $79K |
| 80306 | <1% | 5,946 | $73K | |
| 99000 | <1% | 3,677 | $72K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 2,814 | $71K |
| Z6400 | <1% | 2,524 | $67K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 1,744 | $67K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 9,366 | $65K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 5,723 | $63K |
| 83690 | <1% | 12,563 | $62K | |
| 87040 | <1% | 4,523 | $61K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 7,385 | $58K |
| 0301 | <1% | 1,451 | $58K | |
| H1003 | Prenatal care, at-risk enhanced service; education | <1% | 5,196 | $57K |
| 85730 | <1% | 10,029 | $56K | |
| 99284 | Emergency room visit (serious) | <1% | 1,072 | $53K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 793 | $49K |
| A0429 | Emergency ambulance ride, basic life support | <1% | 1,143 | $47K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 3,321 | $47K |
| 84703 | <1% | 8,510 | $47K | |
| 83605 | <1% | 4,522 | $44K | |
| 76801 | <1% | 997 | $44K | |
| 86403 | <1% | 2,869 | $44K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,921 | $42K |
| 85610 | <1% | 10,297 | $42K | |
| 0360 | <1% | 549 | $42K | |
| 59025 | Fetal non-stress test | <1% | 2,388 | $36K |
| 76830 | Ultrasound, transvaginal | <1% | 808 | $35K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 1,640 | $35K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,035 | $35K |
| 87420 | <1% | 2,220 | $34K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 1,342 | $34K |
| 73562 | <1% | 1,286 | $33K | |
| S9446 | Patient education, not otherwise classified, non-physician provider, group, per session | <1% | 2,587 | $32K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,311 | $32K |
| 73610 | <1% | 1,132 | $30K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 4,165 | $29K |
| 90715 | <1% | 1,064 | $29K | |
| 99070 | <1% | 1,745 | $29K | |
| 70486 | <1% | 229 | $28K | |
| 73630 | <1% | 1,289 | $28K | |
| 0272 | <1% | 3,710 | $28K | |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | <1% | 3,453 | $27K |
| 87070 | <1% | 3,686 | $27K | |
| 85027 | <1% | 4,805 | $27K | |
| 87077 | <1% | 2,637 | $25K | |
| 84702 | <1% | 1,982 | $25K | |
| Z6204 | <1% | 898 | $20K | |
| 73030 | <1% | 771 | $19K | |
| 0761 | <1% | 1,397 | $18K | |
| 73130 | <1% | 637 | $18K | |
| H1002 | Prenatal care, at risk enhanced service; care coordination | <1% | 194 | $18K |
| 0710 | <1% | 1,332 | $18K | |
| 0459 | <1% | 456 | $17K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 397 | $17K |
| Z6304 | <1% | 664 | $17K | |
| H2000 | Comprehensive multidisciplinary evaluation | <1% | 497 | $17K |
| 87186 | <1% | 2,701 | $17K | |
| 93971 | <1% | 243 | $16K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 2,255 | $16K |
| J1815 | Injection, insulin, per 5 units | <1% | 221 | $16K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 737 | $16K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 314 | $15K |
| 82962 | <1% | 3,506 | $15K | |
| 96156 | <1% | 1,252 | $14K | |
| 86140 | <1% | 3,861 | $14K | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 764 | $14K |
| 97803 | <1% | 1,416 | $14K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 122 | $13K |
| 73110 | <1% | 375 | $13K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 98 | $13K |
| 97139 | <1% | 938 | $12K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 474 | $12K |
| 74022 | <1% | 418 | $12K | |
| 82803 | <1% | 650 | $11K | |
| 99401 | <1% | 1,075 | $11K | |
| 85379 | <1% | 1,354 | $10K | |
| 72100 | <1% | 408 | $10K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 729 | $10K |
| 85007 | <1% | 4,799 | $10K | |
| Z6406 | <1% | 391 | $9K | |
| 81025 | <1% | 2,139 | $9K | |
| 83735 | <1% | 2,015 | $9K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 846 | $9K |
| 99285 | Emergency room visit (most serious) | <1% | 68 | $9K |
| 0271 | <1% | 3,503 | $9K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,765 | $8K |
| 80061 | Lipid panel | <1% | 722 | $8K |
| 97799 | <1% | 594 | $7K | |
| J2704 | Injection, propofol, 10 mg | <1% | 324 | $7K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,254 | $7K |
| 81003 | <1% | 2,277 | $6K | |
| S9452 | Nutrition classes, non-physician provider, per session | <1% | 549 | $6K |
| 92523 | <1% | 105 | $6K | |
| A4217 | Sterile water/saline, 500 ml | <1% | 987 | $6K |
| 0160 | <1% | 53 | $6K | |
| 36416 | <1% | 2,273 | $6K | |
| 86256 | <1% | 674 | $6K | |
| 80143 | <1% | 499 | $6K | |
| 80179 | <1% | 503 | $6K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,530 | $5K |
| 86901 | <1% | 2,099 | $5K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 311 | $5K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 39 | $5K |
| 86900 | <1% | 2,088 | $5K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 140 | $4K |
| 93970 | <1% | 39 | $4K | |
| Z6206 | <1% | 342 | $4K | |
| 96151 | <1% | 462 | $4K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 42 | $4K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 253 | $4K |
| 0750 | <1% | 135 | $4K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 624 | $4K |
| 36600 | <1% | 396 | $4K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 527 | $4K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 863 | $4K |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 70 | $3K |
| Z6306 | <1% | 260 | $3K | |
| 0440 | <1% | 55 | $3K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 572 | $3K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 798 | $3K |
| A4649 | Surgical supply; miscellaneous | <1% | 2,089 | $3K |
| 74018 | <1% | 64 | $2K | |
| 76775 | <1% | 89 | $2K | |
| 96152 | <1% | 211 | $2K | |
| Z6408 | <1% | 218 | $2K | |
| 97163 | <1% | 64 | $2K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 12 | $2K |
| 0320 | <1% | 238 | $2K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 48 | $2K |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 145 | $2K |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 165 | $2K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 214 | $2K |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 272 | $2K |
| 71101 | <1% | 27 | $2K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 14 | $2K |
| 73080 | <1% | 42 | $1K | |
| 73590 | <1% | 24 | $1K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 65 | $1K |
| 86850 | <1% | 347 | $1K | |
| 85651 | <1% | 280 | $1K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 29 | $883.90 |
| 92521 | <1% | 19 | $863.50 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 65 | $840.00 |
| Z6308 | <1% | 33 | $808.34 | |
| S0164 | Injection, pantoprazole sodium, 40 mg | <1% | 47 | $795.71 |
| 99078 | <1% | 156 | $742.09 | |
| 72040 | <1% | 42 | $741.14 | |
| 82150 | <1% | 204 | $710.04 | |
| 97804 | <1% | 132 | $699.48 | |
| 73140 | <1% | 68 | $651.74 | |
| 88312 | <1% | 115 | $614.20 | |
| 86308 | <1% | 70 | $510.02 | |
| 87631 | <1% | 13 | $499.89 | |
| 97750 | <1% | 18 | $478.63 | |
| 71020 | <1% | 12 | $447.24 | |
| 0258 | <1% | 149 | $432.93 | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 14 | $397.38 |
| 88313 | <1% | 46 | $282.93 | |
| 0636 | <1% | 234 | $262.29 | |
| 87184 | <1% | 88 | $204.88 | |
| 0300 | <1% | 149 | $164.22 | |
| 82728 | <1% | 14 | $152.66 | |
| 83615 | <1% | 28 | $149.37 | |
| J3105 | Injection, terbutaline sulfate, up to 1 mg | <1% | 15 | $139.34 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 16 | $105.87 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 15 | $92.98 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | <1% | 14 | $81.81 |
| 82010 | <1% | 16 | $72.66 | |
| 73090 | <1% | 12 | $71.14 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 13 | $45.49 |
| 82270 | <1% | 26 | $38.21 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 14 | $31.21 |
| 0305 | 0% | 183 | $0.00 | |
| Q4051 | Splint supplies, miscellaneous (includes thermoplastics, strapping, fasteners, padding and other supplies) | 0% | 35 | $0.00 |
| 99072 | 0% | 60 | $0.00 | |
| 0302 | 0% | 33 | $0.00 | |
| 99499 | 0% | 21 | $0.00 | |
| 0637 | 0% | 82 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMARSH, LINDA (SENIOR VICE PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Ahmc Garfield Medical Center LP | Monterey Park, CA | $17.83M |
| Ahmc Anaheim Regional Medical | Anaheim, CA | $14.21M |
| Ahmc Monterey Park Hospital LP | Monterey Park, CA | $10.85M |
| Ahmc Greater El Monte Community | South El Monte, CA | $9.17M |
| Ahmc San Gabriel Valley Medical | San Gabriel, CA | $6.96M |
| Alhambra Hospital Medical Center, LP | Alhambra, CA | $6.90M |
| Ahmc Seton Medical Center LLC | Daly City, CA | $5.21M |
| Alhambra Hospital Medical Center, LP | Alhambra, CA | $1.57M |
| Ahmc San Gabriel Valley Medical | San Gabriel, CA | $249K |
| Alhambra Hospital Medical Center, LP | Alhambra, CA | $176K |
| Alhambra Hospital Medical Center, LP | Alhambra, CA | $34K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.